OFDT Documentation

  • Recherche
    • Recherche simple
    • Périodiques
    • Publications OFDT
    • Textes législatifs
    • Nos dernières publications
  • Sélections
    • Usages de drogues à l’adolescence
    • Usages de drogues féminins
    • Drogues et sécurité routière
    • Addictions en milieu professionnel
    • Addictions en milieu carcéral
  • À propos
    • Présentation
    • Contact
Aide

Rechercher

Aide

Recherche avancée

Périodiques

Portail documentaire

  • A-
  • A
  • A+

Site OFDT

Historique

Accès réservé à l'OFDT et ses partenaires



Mot de passe oublié ?
  • Recherche
    • Recherche simple
    • Périodiques
    • Publications OFDT
    • Textes législatifs
    • Nos dernières publications
  • Sélections
    • Usages de drogues à l’adolescence
    • Usages de drogues féminins
    • Drogues et sécurité routière
    • Addictions en milieu professionnel
    • Addictions en milieu carcéral
  • À propos
    • Présentation
    • Contact

Rechercher

Aide

Recherche avancée

Périodiques

  1. Accueil
  2. Retour
Addiction, Vol.114, n°12 - December 2019
Ajouter à la sélection Ajouter à la sélection
Lien externe Lien externe
Bulletin de Périodique
Addiction , Vol.114, n°12 - December 2019
Paru le : 01/12/2019
Année : 2019
Page(s) : 2101-2292
Langue(s) : Anglais

Note de contenu :

CONTENTS:
- Enhancing engagement in hepatitis C care among people who inject drugs [Editorial]. Marshall A.D., Madden A., Treloar C., p. 2104-2106.
- Supervised consumption sites: a nuanced assessment of the causal evidence [Addiction opinion and debate]. Caulkins J.P., Pardo B., Kilmer B., p. 2109-2115.
- How much do we need to know about supervised consumption sites? It depends who's asking. Satel S., p. 2116-2117.
- The need to broaden and strengthen the evidence base for supervised consumption sites. May T., Holloway K., Bennett T., p. 2117-2118.
- The unmaking of 'evil': claiming space for rational discourse on US drug policy. Frydl K.J., p. 2119-2120.
- The benefits of evaluating literatures with essays. Caulkins J.P., Pardo B., Kilmer B., p. 2120-2121.
- Pharmacotherapy for methamphetamine/amphetamine use disorder-a systematic review and meta-analysis. Chan B., Freeman M., Kondo K., Ayers C., Montgomery J., Paynter R., et al., p. 2122-2136.
- Effects of repetitive transcranial magnetic stimulation (rTMS) on craving and substance consumption in patients with substance dependence: a systematic review and meta-analysis. Zhang J.J.Q., Fong K.N.K., Ouyang R.G., Siu A.M.H., Kranz G.S., p. 2137-2149.
- Changes in associations of prescription opioid use disorder and illegal behaviors among adults in the United States from 2002 to 20. Mintz C.M., Hartz S.M., Borodovsky J.T., Bierut L.J., Grucza R.A., p. 2150-2159.
- Commentary on Mintz et al. (2019): Unintended or intended? Coming to grips with the opioid crisis. Dart R.C., p. 2160-2161.
- Associations between young adult marijuana outcomes and availability of medical marijuana dispensaries and storefront signage. Shih R.A., Rodriguez A., Parast L., Pedersen E.R., Tucker J.S., Troxel W.M., et al., p. 2162-2170.
- Commentary on Shih et al. (2019): Lessons from alcohol outlet availability. Wilkinson C., p. 2171-2172.
- Trajectories of injection drug use among people who use drugs in Vancouver, Canada, 1996-2017: growth mixture modeling using data from prospective cohort studies. Dong H., Hayashi K., Singer J., Milloy M.J., DeBeck K., Wood E., et al., p. 2173-2186.
- Risky driving behaviours among stimulant drug users and the role of aggression: findings from a national survey. Hayley A.C., Hart C.L., O'Malley K.Y., Stough C.K.K., Downey L.A., p. 2187-2196.
- Perceived relative harm of using e-cigarettes predicts future product switching among US adult cigarette and e-cigarette dual users. Persoskie A., O'Brien E.K., Poonai K., p. 2197-2205.
- Cost-effectiveness of population-level proactive tobacco cessation outreach among socio-economically disadvantaged smokers: evaluation of a randomized control trial. Thao V., Nyman J.A., Nelson D.B., Joseph A.M., Clothier B., Hammett P.J., et al., p. 2206-2216.
- Schizophrenia is associated with increased risk of subsequent substance abuse diagnosis: A nation-wide population-based register study. Petersen S.M., Toftdahl N.G., Nordentoft M., Hjorthoj C., p. 2217-2226.
- Commentary on Petersen et al. (2019): Development of problematic substance use in the years that follow diagnosis of schizophrenia. Lappin J.M., p. 2227-2228.
- Genetic and environmental risk factors in the non-medical use of over-the-counter or prescribed analgesics, and their relationship to major classes of licit and illicit substance use and misuse in a population-based sample of young adult twins. Gillespie N.A., Bates T.C., Hickie I.B., Medland S.E., Verhulst B., Kirkpatrick R.M., et al., p. 2229-2240.
- Association between experience of racial discrimination and hazardous alcohol use among Maori in Aotearoa New Zealand. Winter T., Riordan B.C., Surace A., Scarf D., p. 2241-2246.
- Comparison of e-cigarette use characteristics between exclusive e-cigarette users and dual e-cigarette and conventional cigarette users: an on-line survey in France. Berlin I., Nalpas B., Targhetta R., Perney P., p. 2247-2251.
- Assessment of the accuracy of salivary cotinine readings from NicAlert strips against a liquid chromatography tandem mass spectrometry assay in self-reported non-smokers who passed carbon monoxide but failed NicAlert validation. Etter J.F., p. 2252-2256.
- Adding quality to quantity in randomized controlled trials of addiction prevention and treatment: a new framework to facilitate the integration of qualitative research. Maher L., Neale J., p. 2257-2266.
- Cost-effectiveness of scaling-up HCV prevention and treatment in the United States for people who inject drugs. Barbosa C., Fraser H., Hoerger T.J., Leib A., Havens J.R., Young A., et al., p. 2267-2278.
- Commentary on Barbosa et al. (2019): The value of using community simulation modeling to achieve HCV elimination targets in people who inject drugs. Schackman B.R., Meisel Z.F., p. 2279-2280.
Lien : https://onlinelibrary.wiley.com/toc/13600443/2019/114/12
Cote : Abonnement

Dépouillements

Ajouter le résultat à votre sélection
Supervised consumption sites: a nuanced assessment of the causal evidence [Addiction opinion and debate]

Supervised consumption sites: a nuanced assessment of the causal evidence [Addiction opinion and debate]

J. P. CAULKINS ; B. PARDO ; B. KILMER | 2019
Dans Addiction (Vol.114, n°12, December 2019) Article : Périodique
BACKGROUND AND AIMS: Supervised consumption sites (SCS) operate in more than 10 countries. SCS have mostly emerged as a bottom-up response to crises, first to HIV/AIDS and now overdose deaths, in ways that make rigorous evaluation difficult. Opi[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
Comparison of e-cigarette use characteristics between exclusive e-cigarette users and dual e-cigarette and conventional cigarette users: an on-line survey in France

Comparison of e-cigarette use characteristics between exclusive e-cigarette users and dual e-cigarette and conventional cigarette users: an on-line survey in France

I. BERLIN ; B. NALPAS ; R. TARGHETTA ; P. PERNEY | 2019
Dans Addiction (Vol.114, n°12, December 2019) Article : Périodique
BACKGROUND AND AIMS: Completely substituting e-cigarettes (EC) for combustible tobacco cigarettes reduces exposure to toxicants and carcinogens. However, a large proportion of EC users (dual users) continue to smoke conventional cigarettes. This[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
Adding quality to quantity in randomized controlled trials of addiction prevention and treatment: a new framework to facilitate the integration of qualitative research

Adding quality to quantity in randomized controlled trials of addiction prevention and treatment: a new framework to facilitate the integration of qualitative research

L. MAHER ; J. NEALE | 2019
Dans Addiction (Vol.114, n°12, December 2019) Article : Périodique
BACKGROUND AND AIMS: Randomized controlled trials (RCTs) are important for evaluating interventions, and qualitative research is increasingly recognized as being crucial to the success of this enterprise. We aimed to describe and demonstrate a t[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
Nouvelle recherche Votre compte

Contact

OFDT

69 rue de Varenne
75700 PARIS

Tel : (+33) 01 41 62 77 16

Accès rapides

  • L’établissement
  • Les partenaires
  • La lettre d’information

Avertissement

Toute inclusion dans la base documentaire ne vaut pas crédit scientifique de l'OFDT

Contact

OFDT

69 rue de Varenne
75700 PARIS

Tel : (+33) 01 41 62 77 16

Accès rapides

  • L’établissement
  • Les partenaires
  • La lettre d’information

Avertissement

Toute inclusion dans la base documentaire ne vaut pas crédit scientifique de l'OFDT

Suivez-nous

  • Traitement des données personnelles
  • Mentions légales
  • Plan du site